子宮操作設備市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球子宮操縱設備市場估值達 3.67 億美元，預計 2025 年至 2034 年期間的複合年成長率為 5.2%。這一成長是由子宮內膜異位症和子宮肌瘤等婦科疾病的發生率不斷上升所推動的，這推動了對子宮切除術和肌瘤切除術等外科手術的需求。此外，輔助生殖技術的進步、微創手術技術的日益採用以及向門診護理環境的轉變在擴大市場方面發揮著至關重要的作用。這些因素，加上人們對女性健康的認知不斷提高以及創新醫療設備的普及，促使子宮操縱裝置在全球範圍內廣泛應用。由於高度重視改善患者的治療效果和手術效率，醫療保健提供者擴大轉向使用先進的工具來提高婦科手術的精確度。

根據設備類型，市場分為一次性子宮操縱設備及可重複使用子宮操縱設備，其中一次性設備佔據主導地位。一次性設備因其便利性和能夠滿足嚴格的無菌標準而受到青睞，2024 年的價值為 2.282 億美元。這些一次性設備無需進行消毒過程，為醫療機構節省了時間和資源，特別是在高容量手術環境中。隨著強調感染控制和手術安全的法規日益增多，一次性子宮操作器的採用也得到了進一步的推動。隨著醫院和門診護理中心優先考慮效率和合規性，一次性設備的需求持續成長。

根據最終用戶，子宮操縱設備市場包括醫院、婦科診所和門診手術中心。醫院仍然是婦科手術的主要場所，例如肌瘤切除術、子宮切除術、生育手術和子宮內膜異位症治療，2024 年醫院支出為 1.981 億美元。人們對微創手術（包括全腹腔鏡子宮切除術 (TLH)）的偏好日益增加，推動了對支持精準度和縮短恢復時間的子宮操作設備的需求。隨著患者偏好轉向微創治療，醫院擴大配備先進的工具來提高手術效果。

美國子宮操縱設備市場價值在 2024 年達到 1.154 億美元，預計到 2034 年將以 4.4% 的複合年成長率成長。子宮肌瘤和子宮內膜異位症等婦科疾病的發生率不斷增加，推動了對手術解決方案的需求。美國市場的特點是早期採用創新醫療技術，對優先考慮安全性、準確性和易用性的產品的需求很高。一次性子宮操作器因其在降低手術期間感染風險方面的作用而越來越受歡迎，使其成為全國各地醫院和門診手術中心的首選。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 婦科疾病發生率不斷上升
    • 認知度和診斷率不斷提高
    • 產品技術的進步以及外科手術的增多
  • 產業陷阱與挑戰
    • 手續費用高且監管嚴格
• 成長潛力分析
• 監管格局
• 技術格局
• 報銷場景
• 差距分析
• 波特的分析
• PESTEL 分析
• 未來市場趨勢

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按類型，2021 — 2034 年

• 主要趨勢
• 一次性的
• 可重複使用的

第6章：市場估計與預測：按應用，2021 — 2034 年

• 主要趨勢
• 全腹腔鏡子宮切除術 (TLH)
• 腹腔鏡子宮切除術 (LSH)
• 腹腔鏡輔助陰道子宮切除術 (LAVH)
• 其他應用

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 婦科診所
• 門診手術中心

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• B. Braun
• Bissinger
• Conkin surgical instruments
• Conmed
• Coopersurgical
• Karl storz
• Laborie
• Lsi solutions
• Purple surgical
• Richard wolf
• Utah medical products

The Global Uterine Manipulation Devices Market reached a valuation of USD 367 million in 2024 and is projected to expand at a CAGR of 5.2% between 2025 and 2034. This growth is fueled by the increasing prevalence of gynecological conditions such as endometriosis and uterine fibroids, which are driving the demand for surgical interventions like hysterectomies and myomectomies. Additionally, advancements in assisted reproductive technologies, the rising adoption of minimally invasive surgical techniques, and the shift toward outpatient care settings are playing a crucial role in expanding the market. These factors, combined with growing awareness of women's health and the availability of innovative medical devices, are contributing to the widespread adoption of uterine manipulation devices globally. With a strong focus on improving patient outcomes and procedural efficiency, healthcare providers are increasingly turning to advanced tools that enhance precision during gynecological surgeries.

The market is segmented by device type into disposable and reusable uterine manipulation devices, with disposable devices maintaining a dominant share. Valued at USD 228.2 million in 2024, disposable devices are favored for their convenience and ability to meet stringent sterility standards. These single-use devices eliminate the need for sterilization processes, saving time and resources for healthcare facilities, particularly in high-volume surgical environments. The adoption of disposable uterine manipulators is further bolstered by increasing regulations emphasizing infection control and surgical safety. As hospitals and outpatient care centers prioritize efficiency and compliance, the demand for disposable devices continues to grow.

By end-user, the uterine manipulation devices market encompasses hospitals, gynecology clinics, and ambulatory surgery centers. Hospitals, which accounted for USD 198.1 million in 2024, remain the primary venues for gynecological surgeries such as myomectomies, hysterectomies, fertility procedures, and treatments for endometriosis. The rising preference for minimally invasive surgeries, including total laparoscopic hysterectomy (TLH), is driving the demand for uterine manipulation devices that support precision and reduced recovery times. As patient preferences shift toward minimally invasive options, hospitals are increasingly equipping themselves with advanced tools to enhance surgical outcomes.

The U.S. uterine manipulation devices market, valued at USD 115.4 million in 2024, is expected to grow at a CAGR of 4.4% through 2034. The increasing incidence of gynecological diseases such as uterine fibroids and endometriosis is fueling the demand for surgical solutions. The U.S. market is characterized by the early adoption of innovative medical technologies, creating high demand for products that prioritize safety, accuracy, and ease of use. Disposable uterine manipulators, in particular, are gaining popularity for their role in minimizing infection risks during surgeries, making them a preferred choice in hospitals and ambulatory surgery centers across the country.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of gynecological disorders
    • 3.2.1.2 Growing awareness and diagnosis rates
    • 3.2.1.3 Technological advancements in products coupled with rise in surgical procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of procedures and stringent regulations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Disposable
• 5.3 Reusable

Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Total Laparoscopy Hysterectomy (TLH)
• 6.3 Laparoscopic Supracervical Hysterectomy (LSH)
• 6.4 Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Gynecology clinics
• 7.4 Ambulatory surgery centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Bissinger
• 9.3 Conkin surgical instruments
• 9.4 Conmed
• 9.5 Coopersurgical
• 9.6 Karl storz
• 9.7 Laborie
• 9.8 Lsi solutions
• 9.9 Purple surgical
• 9.10 Richard wolf
• 9.11 Utah medical products